These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10547173)

  • 21. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fatality rate in the epidemiology of meningococcal disease: study in the region of Campinas, SP, Brazil, 1993 to 1998].
    Donalisio MR; Kemp B; Rocha MM; Ramalheira RM
    Rev Saude Publica; 2000 Dec; 34(6):589-95. PubMed ID: 11175603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter surveillance of invasive meningococcal infections in children.
    Kaplan SL; Schutze GE; Leake JA; Barson WJ; Halasa NB; Byington CL; Woods CR; Tan TQ; Hoffman JA; Wald ER; Edwards KM; Mason EO
    Pediatrics; 2006 Oct; 118(4):e979-84. PubMed ID: 17015517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningitis and bacteremia due to Neisseria meningitidis: clinical and laboratory findings in 69 cases from Orebro county, 1965 to 1977.
    Olcén P; Barr J; Kjellander J
    Scand J Infect Dis; 1979; 11(2):111-9. PubMed ID: 111345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.
    Knol MJ; Hahné SJM; Lucidarme J; Campbell H; de Melker HE; Gray SJ; Borrow R; Ladhani SN; Ramsay ME; van der Ende A
    Lancet Public Health; 2017 Oct; 2(10):e473-e482. PubMed ID: 29253430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of meningococcal meningitis and changes in the surveillance system in Poland, 1970-2006.
    Gryniewicz O; Kolbusz J; Rosinska M; Zielinski A; Stefanoff P
    Euro Surveill; 2007 May; 12(5):E7-8. PubMed ID: 17991397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active surveillance of meningococcal meningitis in Poland.
    Tyski S; Grzybowska W; Lind I
    Cent Eur J Public Health; 1998 Aug; 6(3):219-24. PubMed ID: 9787924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group.
    Connolly M; Noah N
    Epidemiol Infect; 1999 Feb; 122(1):41-9. PubMed ID: 10098784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The burden of hospitalizations for meningococcal infection in Spain (1997-2008).
    Gil-Prieto R; García-García L; Alvaro-Meca A; González-Escalada A; Viguera Ester P; Gil De Miguel A
    Vaccine; 2011 Aug; 29(34):5765-70. PubMed ID: 21664402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serogroup Y meningococcal disease in Chicago, 1991-1997.
    Racoosin JA; Whitney CG; Conover CS; Diaz PS
    JAMA; 1998 Dec 23-30; 280(24):2094-8. PubMed ID: 9875877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Australian Meningococcal Surveillance Programme annual report, 2014.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E221-8. PubMed ID: 27522133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of meningococcal serogroup C conjugate vaccine in Scotland.
    Mooney JD; Christie P; Robertson C; Clarke SC
    Clin Infect Dis; 2004 Aug; 39(3):349-56. PubMed ID: 15307001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningococcal disease in Dallas County, Texas: results of a six-year population-based study.
    Pastor P; Medley FB; Murphy TV
    Pediatr Infect Dis J; 2000 Apr; 19(4):324-8. PubMed ID: 10783023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Meningococcal disease in the province of Córdoba (1983-1987].
    Martínez de la Iglesia J; Montero Pérez FJ; Fernández-Crehuet Navajas R
    Enferm Infecc Microbiol Clin; 1990; 8(7):420-5. PubMed ID: 2152477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National surveillance for meningococcal disease in Japan, 1999-2014.
    Fukusumi M; Kamiya H; Takahashi H; Kanai M; Hachisu Y; Saitoh T; Ohnishi M; Oishi K; Sunagawa T
    Vaccine; 2016 Jul; 34(34):4068-71. PubMed ID: 27291085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningococcal disease in Slovenia (1993-1999): serogroups and susceptibility to antibiotics. Slovenian Meningitis Study Group.
    Cizman M; Gubina M; Paragi M; Beovic B; Lesnicar G
    Int J Antimicrob Agents; 2001 Jan; 17(1):27-31. PubMed ID: 11137645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of Neisseria meningitidis isolates causing fatal disease.
    Jacobsson S; Olcén P; Löfdahl M; Fredlund H; Mölling P
    Scand J Infect Dis; 2008; 40(9):734-44. PubMed ID: 19086340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.